Bird Global Inc.
13F holders, Q4 2025 (December 31)1holders
0new positions
0sold out
$76.49avg. 13F price*
At the end of Q4 2025, 1 institutions reported holding Bird Global Inc. in their 13F filings, unchanged from Q3 2025. 0 opened new positions and 0 sold out. The largest holder was Accent Capital Management, LLC ($14K).
- Company
- Bird Global Inc.
- Filed as
- BRIDGEBIO PHARMA INC (Q4 2025)
- CUSIP
- 09077J107
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| Accent Capital Management, LLC | 0.01% | No change | 187 | $14K |
"% of holder's portfolio" is BIRD GLOBAL INC's weight in each manager's 13F, not the share of Bird Global Inc. the manager owns.